Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WV/Huntington
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Huntington, WV

Studies commonly pay $75 to $4,500 per completed study

57 clinical trials are currently recruiting participants within 30 miles of Huntington. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

57studies recruiting
4+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Huntington right now

Top 25 of 57 recruiting studies, sorted by proximity — each links to its official registry page

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT04322318)

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer Phase 3 Interventional 868 participants sought
Edwards Comprehensive Cancer Center ( Site 4015) — Huntington, West Virginia (0.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06077760)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Neoplasms, Arteriovenous Malformation of Central Nervous System N/A Observational 50,000 participants sought
St. Mary's Medical Center — Huntington, West Virginia (0.8 mi) · Sponsor: The Radiosurgery Society
See eligibility & contact on ClinicalTrials.gov (NCT01885299)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06876714)

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Primary Biliary Cholangitis (PBC) Phase 3 Interventional 276 participants sought
University Physicians and Surgeons Inc, dba Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: Ipsen
See eligibility & contact on ClinicalTrials.gov (NCT06016842)

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Phase 2 Interventional 474 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632977)

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

Chronic Migraine in Children Phase 3 Interventional 285 participants sought
Marshall University Medical Center — Huntington, West Virginia (0.8 mi) · Sponsor: H. Lundbeck A/S
See eligibility & contact on ClinicalTrials.gov (NCT04965675)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06498635)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02402244)

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05327686)

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

Migraine Disorders Phase 4 Interventional 132 participants sought
Upsher-Smith Clinical Trial Site #9 — Huntington, West Virginia (0.8 mi) · Sponsor: Upsher-Smith Laboratories
See eligibility & contact on ClinicalTrials.gov (NCT04748601)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Prediabetic State, Atherosclerosis Phase 4 Interventional 7,410 participants sought
Huntington VA Medical Center, Huntington, WV — Huntington, West Virginia (0.8 mi) · Sponsor: VA Office of Research and Development
See eligibility & contact on ClinicalTrials.gov (NCT02915198)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8 Phase 2 Interventional 2,900 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564377)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 626 participants sought
Local Institution - Unk064 — Huntington, West Virginia (0.8 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04613596)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05675410)

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2, Phase 3 Interventional 378 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06616584)

Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

Anterior Cruciate Ligament Rupture N/A Observational 450 participants sought
Marshall University — Huntington, West Virginia (0.8 mi) · Sponsor: Marshall University
See eligibility & contact on ClinicalTrials.gov (NCT06294314)

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Hepatitis Phase 3 Interventional 350 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: Bausch Health Americas, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07428538)
Actively enrolling

Studies you may be able to join near Huntington

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Huntington

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Research Systems

★ 3.5
7 Stonecrest Dr, Huntington, WV 25701
(304) 529-4453
"Had a great experience getting a drug screening at Health Research Systems in Huntington, WV. The staff was courteous, efficient, and kept everything…"
— Gabriels Travel Secrets, 5★

Marshall University Joan C. Edwards School of Medicine

★ 4.8
1600 Medical Center Dr, Huntington, WV 25701
(304) 691-1700
"Wonderful campus, friendly staff, and delightful students"
— Sunny “SUNNY” Sturgell- Morris, 5★

Marshall Health

★ 2.3
1600 Medical Center Dr, Huntington, WV 25701
(304) 691-1600

CAMC Clinical Trials Center

★ 5.0
3100 MacCorkle Ave SE #806, Charleston, WV 25304
(304) 388-9944

Clinical trials in Huntington: what's recruiting

The Huntington area currently has 57 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Huntington, the most active research areas are:

  • Cancer & Oncology17 studies
  • Liver & Kidney4 studies
  • Brain & Mental Health1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Huntington, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Huntington

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Huntington participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Huntington pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Huntington?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Huntington safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Huntington?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Huntington.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Huntington typically complete one or two studies per year.

Paid clinical trials near Huntington

Other metros within reach

Columbus, OH1,340 Lexington, KY466 Cincinnati, OH1,131 Dayton, OH310 Canton, OH307 Roanoke, VA197 Akron, OH394 Asheville, NC120

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts